You searched for "OCT "
Clinical Applications of Optical Coherence Tomography Angiography
Clinical Applications of Optical Coherence Tomography Angiography provides an informative, up-to-date review of the numerous applications of OCTA in ophthalmology. This book highlights the ways in which this relatively recent non-invasive imaging technique has been an invaluable tool for our...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
4 February 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...
OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)
3 April 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...
The Retinal Atlas (2nd Edition)
1 August 2017
| Shirley Hancock
|
EYE - Vitreo-Retinal
Those readers familiar with the first edition of The Retinal Atlas will appreciate the comprehensive nature of this publication, and this latest version incorporates retinal images generated by recently developed imaging technology. As the title suggests, this hardcover version is...
Outcomes of treat & extend ranibizumab in diabetic macular oedema
1 October 2021
| Ed Rule
|
EYE - Vitreo-Retinal
|
Diabetic macular edema, Outcome predictor, Ranibizumab, Spectral-domain optical coherence tomography, Treat and extend
This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...
Twenty-five years in retina
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...
The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy
1 February 2018
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...
RCOphth Back to Basics - Byte sized topics for all
22 October 2025
Join us for a focused, practical session covering key topics in eye care — from red eyes and corneal ulcers to double vision, disc swelling, and glaucoma. Learn to interpret OCT in Glaucoma and Retina, navigate fundus lesions, and sharpen...
AAO (American Academy of Ophthalmology) 2025
17 October 2025
-20 October 2025
Join the Academy in Orlando for AAO 2025, our 129th annual meeting, Friday Oct. 17 - Monday Oct. 20.
AI breakthrough brings geographic atrophy treatment a step closer
20 September 2021
A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.
The history, evolution and future of optical coherence tomography
25 November 2024
OCT has made it possible to capture a detailed 3D image of the retina, revolutionising ophthalmic diagnostics and optometric practice. Professor Fujimoto, inventor of OCT, visits us from MIT to speak on the transformative impact of OCT and its future role in AI diagnostics, vision and wider healthcare.
Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis
22 August 2023
|
moorfields, Parkinson's disease, Siegfried Wagner, Pearse Keane, UCL Institute of Ophthalmology, early detection
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.
